This document discusses pharmaceutical impurities, which are unwanted chemicals that remain with active pharmaceutical ingredients or develop during formulation or aging. Impurities can come from raw materials, intermediates, reagents, catalysts, solvents, reaction vessels, improper storage, cross contamination, manufacturing errors, packaging errors, microbial contamination, chemical instability, storage containers, or atmospheric contamination. The presence of impurities can affect the efficacy, safety, and purity of pharmaceutical products. Common impurities include metals, microbes, residual solvents, and degradation products. Strict controls are needed in manufacturing to minimize impurities.